furmonertinib
GASTO 10120
Phase 2 small_molecule completed
Quick answer
furmonertinib for Non-small Cell Lung Cancer Metastatic is a Phase 2 program (small_molecule) at Sun Yat-sen University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sun Yat-sen University
- Indication
- Non-small Cell Lung Cancer Metastatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed